To OTC Journal Members: 
 

Thursday Slate of Movers: CVM, C, and NFES All Rocking

This is about the best end of July I can remember in quite some time. Typically, this time of year is very quiet. This year it's different. Apparently the market wants to make up for the beating it gave us in 2008.

At any rate, there are a few big movers in the OTC Journal's world to bring to your attention today, starting with:

Cel-Sci (AMEX: CVM)- breaking out. CVM is having a big day and breaking out. Recommended June 13th at $.36, CVM is getting more ink today in a trade publication related to its therapy in development for Swine Flu. 

As you can see, there's clean break out with a big volume surge. The stock might want to come back and fill the gap. At the current quote of $.53, CVM is 47% higher than it was when I recommended it in June.

The company is getting some Bird Flu related ink today. The lead article at Biomedreports.com is about Bird Flu. CEO Geert Kirsten is canvassed for his comments- and he suggests the government needs to keep funding development. 

It's causing a nice little surge in both volume and price of the stock, and it's just what the doctor ordered. The stock might want to come back and fill the gap at about $.47. Nice winner for you. Click Here to read the whole article.

On Citigroup (NYSE: C): Traders- Take your profit. This was my Monday feature. Remember my article about Citi and Citi When Issued? I suggested now that the investors in the convertible preferreds were able to get out, the pressure would come off and the stock would surge. Right on the money.

I think $3.25 represents a short term ceiling. If you acted on my advice on Monday, you own C or C When Issued at $2.50. That's 30% in three trading days.

Technically, I think the stock is played out for now. It probably needs to pull back or trade sideways for a bit. I still believe it's $4.50 a bit longer term. They will probably do a reverse split. 

Take your 30% and go if you were in this for a trade. Nothing to sneeze at in just a couple of days.

NF Energy (OTC BB: NFES)- Looking at Possible Entry Levels

Clearly my hottest idea right now. If you didn't get it, it's far from too late, but a little patience might be in order. This story is just developing, and the company could grow for years.

The stock printed at $1.70 in the early going today- what a run. That's 146% in six weeks- I introduced this one on June 10th. I've been saying all along it's my favorite China idea right now- they just too profitable to continue to trade where they were. They're too profitable to continue to trade at these levels much longer.

However, whenever a stock makes a run like this, it's prudent to take a step back and look at possible retracement levels. NFES is now entitled to pull back a bit. I'm not positive it will, but if it does here are the thresholds to look at.

$1.32 would be the first level to take a hard look. If that gives way, $1.18 could be in the cards. If the company continues delivering announcements as it has been, $1.18 is not a likely scenario, but if it were to come into play, I'd bet the farm. 

Q2 numbers will be out soon, and the company has forecasted about $2.5 million with about $200k in profits. Q3 should be $5 milllion, and Q4 about $10 million. It's a very back end loaded year. If Q2 numbers are weak, you might get the pullback. If they are strong, I don't see a pullback in the short term. 

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com